Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 238,639,602 papers from all fields of science
Search
Sign In
Create Free Account
NRH - quinone oxidoreductase2
Known as:
NQO2
, dihydronicotinamide riboside - quinone oxidoreductase
, ribosyldihydronicotinamide dehydrogenase
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
NQO2 gene
Broader (1)
Quinone Reductases
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
The potential role of the oxidoreductase, NQO2, in breast cancer
E. Santina
2015
Corpus ID: 87906840
NRH: quinone oxidoreductase 2 (NQO2) is a cytosolic flavin dependent enzyme that is ubiquitously expressed in human tumours. The…
Expand
2014
2014
Design, synthesis and biological evaluation of the novel inhibitors of enzymes NQO1 and NQO2
Mei-Chee Soo
2014
Corpus ID: 83025283
A range of novel and potent NQO1 and NQO2 inhibitors were synthesised. A series of 4-hydroxycoumarin analogues were prepared and…
Expand
2013
2013
DESIGN, SYNTHESIS & EVALUATION OF NOVEL NQO2 INHIBITORS
S. Alnabulsi
,
E. Santina
,
+6 authors
S. Freeman
2013
Corpus ID: 184014676
2012
2012
Targeted Prodrugs of a Novel Platform Anthracycline: Doxazolidine
Daniel L Rudnicki
2012
Corpus ID: 86600104
Doxorubicin (Dox) is an antitumor drug that has been used as a chemotherapeutic agent in the clinic for over 30 years. Dox…
Expand
2011
2011
Structural and mechanistic studies of quinone oxidoreductase II (NQO2)
Rana H. Refaey
2011
Corpus ID: 82051693
Flavoenzymes are a widely diverse group of enzymes that are able to catalyze a variety of different chemical reactions. A growing…
Expand
2010
2010
Abstract 1674: The NQO1 C609T polymorphism is associated with poorer response to AC adjuvant therapy in the treatment of breast cancer
D. Jamieson
,
N. Cresti
,
+5 authors
A. Boddy
2010
Corpus ID: 71994104
Proceedings: AACR 101st Annual Meeting 2010‐‐ Apr 17‐21, 2010; Washington, DC A non-synonymous SNP in the NAD(P)H: Quinone…
Expand
2010
2010
Middleton Mediated Prodrug Cancer Therapy − Quinone Oxidoreductase-2
M. Middleton
,
R. Knox
,
+13 authors
D. Kerr
2010
Corpus ID: 207791310
chemotherapeutic agent. rates of cell division. Thus, the authors propose that a phase II efficacy trial for liver cancer…
Expand
2010
2010
Abstract 668: Synergistic Bcr/Abl degradation effect is triggered by MB12066 with NQO2 inhibitors in chronic myelogenous leukemia
Hyunjoo Kwon
,
J. Heo
,
+9 authors
G. Kweon
2010
Corpus ID: 71536113
Proceedings: AACR 101st Annual Meeting 2010‐‐ Apr 17‐21, 2010; Washington, DC Mutations of Bcr-Abl protein reduce the…
Expand
2006
2006
Characterisation and manipulation of NQO1 and NQO2 activity and expression and the effect on routinely used and experimental cancer chemotherapeutic agents.
D. Jamieson
2006
Corpus ID: 79114308